The Bachmann-Strauss Dystonia & Parkinson Foundation (“BSDPF”) is a 501(c)(3) nonprofit organization dedicated to finding better treatments and cures for the movement disorders dystonia and Parkinson's disease. Founded in 1995 by Louis Bachmann (1916-2000) and Bonnie Strauss, BSDPF has gone on to raise more than $35 million to fund 235 ground-breaking research grants in genetics, drug discovery, deep brain stimulation, and understanding the overlaps between dystonia and Parkinson’s disease, and to provide medical and patient information through its annual Think Tank and Patient Symposium. BSDPF also has contributed $1.4 million to establish four Centers of Excellence at leading medical research institutions across the United States. These Centers at Mount Sinai Beth Israel in New York City, The University of Alabama at Birmingham, The University of California, San Francisco, and the University of Florida in Gainesville, have helped set the standard of care for the dystonia and Parkinson’s community.
In 2014, BSDPF formed a collaborative research alliance with The Michael J. Fox Foundation for Parkinson’s Research. Through the alliance, BSDPF will continue its mission by establishing The Bachmann-Strauss Prize for Excellence in Dystonia Research and enabling support of research exploring the various interfaces between dystonia and Parkinson’s disease.
Click here to learn more about The Bachmann-Strauss Prize for Excellence in Dystonia Research.
Beginning January 1, 2015 BSDPF has discontinued its regular grant making program and refocused its energy and resources in support of its collaborative research alliance with The Michael J. Fox Foundation. For information about funding opportunities available through the collaborative research alliance click here.
From 1995 through 2014 our primary research grants provided seed money for innovative ideas to some of the most promising scientific investigators in the field. These grants have helped to bring greater insight into the causes and cures for dystonia and Parkinson's Disease as well as the interfaces between these two movement disorders. Our initial funding to our grantees has leveraged an additional $117 million from the NIH and other sources.
Click here to see the grants that we have funded.
Click here for our Think Tank & Symposium agendas.